NETHERTON SYNDROME
Clinical trials for NETHERTON SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NETHERTON SYNDROME trials appear
Sign up with your email to follow new studies for NETHERTON SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug offers hope for rare, painful skin condition
Disease control CompletedThis study tested the drug Humira (adalimumab) in 11 people with Netherton syndrome, a rare genetic skin disease that causes severe inflammation, itching, and pain. The goal was to see if Humira could reduce skin symptoms by at least 20% after 3 months of treatment, with a 3-mont…
Matched conditions: NETHERTON SYNDROME
Phase: PHASE2 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated May 17, 2026 20:24 UTC
-
New cream shows promise for rare, severe skin condition
Disease control CompletedThis study tested a cream called SXR1096 in 9 people with Netherton syndrome, a rare genetic skin disease that causes redness, scaling, and itching. The cream aims to block certain enzymes that drive the disease. Participants applied the cream to some skin areas and a placebo to …
Matched conditions: NETHERTON SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: Sixera Pharma • Aim: Disease control
Last updated May 17, 2026 20:11 UTC
-
Rare skin disease mystery unraveled in new study
Knowledge-focused CompletedThis study looked at 18 people with Netherton syndrome, a rare genetic skin condition, to understand how it progresses and affects the immune system. Researchers measured immune markers in the blood and examined skin changes. The goal was to find new targets for future treatments…
Matched conditions: NETHERTON SYNDROME
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated May 17, 2026 20:10 UTC